You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Award Disclosure
Aryeh Jason · SEC Form 4 · Filed Jun 12, 2026
Award
Calculated transaction value
$0
Aryeh Jason Director
LGND
Transaction date
Jun 5, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed 7 days later
LGND daily price context
Close on/before transaction
$237
Jun 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 2,938 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002001011-26-000103
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.25M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 11, 2026 | $1.13M |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 10, 2026 | $125K |
| Ligand Pharmaceuticals Inc LGND | Award | Jun 5, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND Current | Award | Jun 5, 2026 | $0 |